warfarin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Both warfarin (IPTW aHR, 0.53; 95% CI, 0.38–0.74; p < 0.001) and DOACs (aHR, 0.57; 95% CI, 0.43–0.78; p < 0.001) were associated with lower all-cause mortality compared with no anticoagulation (Table 3, Fig. 2, and Supplementary Fig. 1).”
Quoted verbatim from Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation.. - Study
- cohort
- Population
- Korean patients with end-stage kidney disease on dialysis and nonvalvular atrial fibrillation; warfarin compared with no anticoagulation, inverse-probability-weighted retrospective cohort
Effect 0.53 hazard ratio, 95% CI 0.38 to 0.74
Comparative efficacy and safety of warfarin and direct oral anticoagulants in patients with end-stage kidney disease and atrial fibrillation.2026PMID:41531219Permalink
Keep reading
- Everything the graph holds on warfarin
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PFJ07GE23JTCZAVSZK04QR